PT - JOURNAL ARTICLE AU - Sharma, Lavanya P AU - Balachander, Srinivas AU - Thamby, Abel AU - Bhattacharya, Mahashweta AU - Kishore, Chethana AU - Shanbhag, Vandita AU - Jaisoorya, TS AU - Narayanaswamy, Janardhanan C AU - Arumugham, Shyam Sundar AU - Reddy, YC Janardhan TI - Impact of the COVID-19 Pandemic on the Short-term Course of Obsessive-Compulsive Disorder AID - 10.1101/2020.07.26.20162495 DP - 2020 Jan 01 TA - medRxiv PG - 2020.07.26.20162495 4099 - http://medrxiv.org/content/early/2020/07/29/2020.07.26.20162495.short 4100 - http://medrxiv.org/content/early/2020/07/29/2020.07.26.20162495.full AB - Background There is an understandable concern that obsessive-compulsive disorder (OCD) may worsen during the COVID-19 pandemic, but there is little empirical data. We report the impact of COVID-19 pandemic on the short-term course of OCD. We also assessed for predictors of relapse and emergence of COVID–19–themed obsessive–compulsive symptoms.Methods A cohort of patients with a primary diagnosis of OCD (n=240) who were on regular follow-up at a tertiary care specialty OCD Clinic in India were assessed telephonically, about 2 months after the declaration of the pandemic (‘pandemic’ cohort). Data from the medical records of an independent set of patients with OCD (n=207) who were followed–up during the same period, one year prior, was used for comparison (historical controls).Results The ‘pandemic’ group and historical controls did not differ in the trajectories of the Yale-Brown Obsessive-Compulsive Scale (YBOCS) scores (Chi-square for likelihood-ratio test of the Group × Time interaction = 2.73, p= 0.255) and relapse rate [21% vs 20%, adjusted odds ratio = 0.81 (95% CI 0.41 -1.59, p=0.535]. Pre-existing contamination symptoms and COVID-19-related health anxiety measured by the COVID-Threat Scale did not predict relapse. Only a small proportion of patients (6%) reported COVID-19-themed obsessive-compulsive symptoms.Limitations Follow-up 2 months after pandemic declaration may be too early understand the true impact.Conclusions The COVID-19 pandemic, at least in the short-run, did not influence the course of illness in those who were on medications. It would be pertinent to evaluate the long-term impact of the pandemic on the course of OCD.View this table:Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis was a non-funded study, done as part of a 'continuum of care' initiative at the OCD Clinic, NIMHANS Bangalore during the COVID-19 pandemic.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institute Ethics Committee, National Instiute of Mental Health & Neurosciences (NIMHANS), BangaloreAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRequests to share anonymized datasheets may be addressed to the corresponding author (SB)